“AI Regulations: Are Global Life Science Collaborations at Risk? 85% of Professionals Sound the Alarm!”
The event also saw the launch of a new whitepaper from ZS and Pistoia Alliance: ‘Are misaligned incentives preventing better patient outcomes in life sciences R&D?’. The joint paper contains insights from 25 industry leaders to explore how to create a future where near-real-time integration of human health data fuels R&D innovation. Other keynotes at the conference were delivered by Dr Genevieve Haliburton from the Chan Zuckerberg Initiative on its rare disease project, which takes a patient-led approach to driving research priorities, by establishing disease-specific data repositories and collaborating closely with scientific, medical and patient communities. Dr Jennifer Van Camp from AbbVie discussed how organizations can leverage clinical, biomarker, and patient real-world data to identify disease comorbidities and drug repurposing opportunities, enhancing evidence-based drug development.
Post Comment